Strategic capabilities The Baker Group positions itself as a technology advancement partner for medical devices, medical informatics, and advanced energy, offering services from business strategy and market analysis to monetization and fundraising guidance. This suggests sales opportunities around end-to-end product development support, licensing deals, or joint development arrangements with OEMs and biotech firms.

Funding readiness With services including investor readiness, due diligence preparation, and fundraising oversight, there is a clear opportunity to engage early-stage startups or spinouts seeking capital, as well as established companies pursuing strategic funding rounds, licensing, or acquisition conversations.

Small team agility A lean team of 2–10 employees indicates potential for high-margin, project-based engagements and quick turnaround times, especially for specialized consulting in product development, market entry, and IP valuation for emerging medical and energy technologies.

Technology-enabled offerings Leveraging Microsoft 365 and related collaboration tools positions the firm to offer scalable, remote-ready advisory services, which can be marketed to global clients in need of cost-effective strategy, competitive analysis, and market planning without heavy on-site requirements.

Regional footprint Offices in Portland, Seattle, and Vancouver BC provide a cross-border North American focus with access to life sciences clusters and innovation ecosystems in the Pacific Northwest, enabling targeted outreach to medical device accelerators, universities, and healthcare tech startups in the region.